Quantcast

Latest Pharmacology Stories

2014-10-20 08:39:37

Company Will Share Report Findings Each Quarter to Track Industry Trends FAIR LAWN, N.J., Oct. 20, 2014 /PRNewswire/ -- AnythingIT/WeedHire (OTCBB: ANYI) today announced the findings of WeedHire's Third Quarter 2014 Cannabis Jobs Report, the industry authority on employment trends in the legal marijuana industry. The findings of the Third Quarter 2014 Cannabis Jobs Report show significant demand by state governments looking to fill regulatory and other positions, including senior...

2014-10-20 08:34:56

LOGIC's New "Closed System" Vaporizer Smokes the Competition at NACS Show POMPANO BEACH, Fla., Oct. 20, 2014 /PRNewswire/ -- LOGIC Technology, a leading electronic cigarette company in the United States, is charging up the competition with the launch of their new LOGIC PRO Advanced Vapor Systems, the first-of-its-kind "closed-system" vaporizing device ever to hit the market. LOGIC PRO Advanced Vapor Systems work in conjunction with revolutionary pre-filled, sealed eLiquid capsules...

2014-10-20 08:33:33

LONDON, October 20, 2014 /PRNewswire/ -- Richmond Pharmacology has extended its capacity with an additional six-bed facility dedicated to screening and out-patient procedures for early phase studies in patients, complementing its existing 68-bed facility within Croydon University Hospital. (Photo: http://photos.prnewswire.com/prnh/20141013/709417-a ) (Photo: http://photos.prnewswire.com/prnh/20141013/709417-b ) The new facility is adaptable to...

2014-10-20 08:32:49

AACHEN, Germany, October 20, 2014 /PRNewswire/ -- Sascha Becker will be appointed to the Executive Board of the pharmaceutical company Gruenenthal and take over the finance unit as Group Chief Financial Officer in the first quarter of 2015. Since 2003, Sascha Becker (43) has been working for Merck and is currently CFO of the biopharmaceutical division of Merck Serono with an annual turnover of 6.3 million Euros and is responsible for 10,000 employees. At Gruenenthal, he will...

2014-10-20 08:32:21

Expands rHuPH20 Production SAN DIEGO, Oct. 20, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration (FDA) has approved new contract manufacturing facilities used in the production of Hylenex(®) recombinant (hyaluronidase human injection). The FDA approved the use of the Cook Pharmica manufacturing facility in Bloomington, Indiana for the production of bulk rHuPH20, the active ingredient used in Hylenex, and the...

2014-10-20 08:31:47

ALBANY, N.Y., Oct. 20, 2014 /PRNewswire/ -- Pharmaceutic Labs announces the opening of its specialty CGMP pharmaceutical outsourcing facility in Albany, NY for admixing, compounding, drug shortages and clinical studies and trials. The company meets and/or exceeds the FDA standards for safety and quality, using 21 CFR Part 210 and 21 CFR Part 211. The 10,000 square foot outsourcing facility was designed to provide the highest levels of quality assurance and quality control. The...

2014-10-20 08:31:18

Providing Support, Resources and Pharmaceutical Grade Cannabis Medicine to Veterans DENVER, Oct. 20, 2014 /PRNewswire/ -- Mary's Medicinals today announced that its 501(c)(3) foundation, Mary's Foundation for Caring, is a 4-Star Sponsor of Operation Grow4Vets, a national, nonpartisan organization focused on providing Veterans with unique products, programs and services to assist them in living with injuries sustained while protecting our freedom....

2014-10-20 08:30:12

DENVER, Oct. 20, 2014 /PRNewswire/ -- AmeriCann, Inc. (ACAN OTCQX), a company that develops cannabis cultivation facilities and provides capital for cannabis entrepreneurs, has partnered with local medical marijuana applicants in the state of Illinois. "AmeriCann's management team members have had extensive first-hand experience with compassionate medical marijuana programs for many years," AmeriCann CEO Tim Keogh stated. "We have seen the tremendous benefits that patients have...

2014-10-20 08:27:27

NEW YORK, Oct. 20, 2014 /PRNewswire/ -- Mapp Biopharmaceutical's valiant effort to produce more of their experimental ZMapp(TM) antibody therapeutic to fight the Ebola outbreak will make the public aware of how difficult and time-consuming the production of pharmaceuticals can be, according to Kalorama Information. The healthcare market research publisher said that while some may be taken aback by the three-month production cycle of this compound, those with industry knowledge are...

2014-10-20 04:21:19

DUBLIN, October 20, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that James Bowling, Interim Chief Financial Officer (CFO), has notified the Board of Directors of his decision to step down from his current role to pursue a new career opportunity as CFO of Severn Trent plc. James will leave Shire at the end of Q1 2015 and the company will commence a search for a new CFO immediately. Flemming Ornskov, Shire's Chief Executive Officer, commented:...


Latest Pharmacology Reference Libraries

Pharmacophobia
2013-12-24 12:55:45

Pharmacophobia or medication phobia, comes from Greek pharmakon, meaning “drug, medicine” and phobos, meaning “fear”, is the fear of the use of pharmacological treatments. In severe, excessive, and irrational cases, it might be a type of specific phobia. While lack of awareness by patient of adverse drug reactions can have a serious consequence, having a phobia of medications can also have serious detrimental effects on the patient’s health. Medication phobia can also lead to...

Generalized Anxiety Disorder
2013-07-25 15:07:54

Generalized Anxiety Disorder (GAD) is an anxiety disorder with worry about normal, everyday situations such as finance, health and wellbeing in relationships (personal and work related) all lasting longer than six months. Symptoms The symptoms of GAD can include but are not limited to difficulty swallowing, rashes, shortness of breath, fidgeting, headaches, tension, nausea, etc. In order for GAD to be ruled as present, the symptoms and feelings must be experiences for at least six...

European Journal of Medical Chemistry
2012-05-12 22:03:06

The European Journal of Medical Chemistry is a peer-reviewed scientific journal for medical chemistry. It is published by Elsevier. It was established in 1966 under the title Chimica Therapeutica. That name was maintained until 1973. Even after changing to its current name in 1974, the journal was still subtitled Chimica Therapeutica until 1981; from 1982 to 1986 it was subtitled Chimie Therapeutique, indicating its French origin. The Journal publishes studies on all aspects of medicinal...

0_3ff7149ca288229c28bcd855846ea8c7
2009-04-28 16:00:11

Bursera graveolens or Palo Santo is a tree indigenous to South America in Argetina, Paraguay, Boliva and coastal areas of Ecuador. Palo Santo means "holy wood" in English and belongs in the same family as frankincense and myrrh. Although it has been used in homeopathic medicine for years, most recently it is the extraction of essential oils that has put this plant in the spotlight. Limonene, a-Terpineol, Menthofuran and Carvone are a few of the oils derived from this plant. Native...

31_c737ff73aa3c47be364b2a8cce214e0c
2005-07-12 18:32:21

Datura wrightii (a poisonous weed) is sometimes used as a hallucinogen. It is commonly called Sacred Datura. Datura wrightii is classified as a deliriant, or an anticholinergic. In the US it is, however, called Western Jimson Weed.

More Articles (5 articles) »
Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related